The research aims to enhance the prediction of early recurrence in hepatocellular carcinoma by refining oncological resectability using specific biomarkers.
Utilized AFP and DCP biomarkers for refinement of oncological resectability assessment.
Identified aggressive subsets within the R group.
Evaluated the potential for improving early recurrence prediction.
Refinement using AFP and DCP allows for identifying a biologically aggressive subset.
May lead to improved early recurrence prediction.
Abstract
Refinement using AFP and DCP identified a biologically aggressive subset within the R group and may improve early recurrence prediction.